Takeda Pharmaceutical to Produce Dengue Fever Vaccine in India
11:43 JST, February 28, 2024
TOKYO (Jiji Press) — Takeda Pharmaceutical Co. said Tuesday that it will begin production of a dengue fever vaccine in India, at a time when the infectious disease is spreading around the world.
Takeda plans to annually produce up to 50 million doses of the Qdenga vaccine in India and boost total annual production capacity for the vaccine to 100 million doses by 2030, including output in Germany.
Production in India is expected to reduce distribution costs and lower prices in Southeast Asian and other counties near the South Asian country.
On Tuesday, Takeda announced a strategic partnership with major Indian drugmaker Biological E. Ltd., including the transfer of technology to manufacture the vaccine.
In Germany, the vaccine is produced in single-dose vials. Meanwhile, the Indian company will produce it in multiple-dose vials to reduce storage and logistics costs.
Dengue fever, an infectious disease transmitted by mosquitoes, is currently endemic in more than 100 countries, with an estimated 390 million people infected every year.
Qdenga is the world’s first dengue fever vaccine that does not require prior testing, such as on recipients’ infection history. It is available in Indonesia, Brazil and elsewhere.
As Takeda hopes the vaccine will be used for government-sponsored inoculation programs around the world, it expects increased production to help make the product more accessible.
"Business" POPULAR ARTICLE
-
Japan Business Circle Calls for China Resuming Visa-Free Travel; Keizai Doyukai Visit to Country Marks 1st in 8 Years
-
Japan’s Major Carmakers to Review Production Bases After Trump Win; Mexico Manufactured Vehicles Could be Hit by Tariffs
-
Japanese Companies Sprucing Up Employee Dorms to Attract New Workers, Keep Young Ones They Have
-
Japan’s Economy Expands Annualised 0.9% in Q3 on Tepid Capex
-
BOJ Policy Normalization to Support Long-Term Growth: Ueda
JN ACCESS RANKING
- Japan Business Circle Calls for China Resuming Visa-Free Travel; Keizai Doyukai Visit to Country Marks 1st in 8 Years
- Streaming Services Boost Anime Popularity Overseas; Former ‘Geeky’ Interest More Beloved Among Gen Z than 3 Major U.S. Sports
- Malaysia Growing in Popularity as Destination for Studying Abroad; British-style Education Available at Low Cost
- ‘Women Over 30 Would Have Uteruses Removed’; Remarks of CPJ Leader, Novelist Naoki Hyakuta Get Wide Attention
- APEC Leaders Vow to Maintain Free Trade System